CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 for Advanced Pancreatic Cancer

News   Jan 07, 2010

 
CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 for Advanced Pancreatic Cancer
 
 
 

RELATED ARTICLES

Hits for a Novel Drug Target Identified for Depression and Pain

News

Novel small molecules have been identified that might be transformed into a new medical treatment of depression and/or even the potential in the treatment of pain.

READ MORE

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

Flow Chemistry Process Development: Johnson Matthey and Snapdragon Chemistry Announce Partnership

News

Johnson Matthey and Snapdragon Chemistry Inc. are pleased to announce that they have entered in to a collaborative agreement to provide integrated continuous manufacturing services – from development to full-scale GMP manufacturing.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE